Clinical Trial Update: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update reports the biodistribution of the 99mTc-PSMA-I&S imaging agent in patients with prostate cancer. Recruitment for the study is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 99mTc-PSMA-I&S

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma | EARLY_Phase 1 | Status: RECRUITING